Asian Biomedicine最新文献

筛选
英文 中文
Cost-effectiveness of digital breast tomosynthesis versus digital mammography for breast cancer screening: a systematic literature review. 数字乳房断层合成与数字乳房x光摄影在乳腺癌筛查中的成本效益:系统的文献综述。
IF 1.4 4区 医学
Asian Biomedicine Pub Date : 2026-08-31 eCollection Date: 2026-08-01 DOI: 10.2478/abm-2026-0025
Supakorn Chansaengpetch, Lisa Stirk, Nigel Armstrong
{"title":"Cost-effectiveness of digital breast tomosynthesis versus digital mammography for breast cancer screening: a systematic literature review.","authors":"Supakorn Chansaengpetch, Lisa Stirk, Nigel Armstrong","doi":"10.2478/abm-2026-0025","DOIUrl":"https://doi.org/10.2478/abm-2026-0025","url":null,"abstract":"<p><strong>Background: </strong>Digital breast tomosynthesis (DBT) is being rapidly adopted and has the potential to improve diagnostic performance compared with digital mammography (DM), the current standard for breast cancer screening. However, its cost-effectiveness remains uncertain, and a systematic synthesis of economic evidence is lacking. Therefore, this study aims to review existing cost-effectiveness analyses of DBT versus DM in average-risk women to inform policy decision-making and identify key considerations for future economic evaluations.</p><p><strong>Methods: </strong>Seven databases (MEDLINE, Embase, KSR Evidence, Cochrane Library, NHSEED, CEA Registry, and RePEc IDEAS) were searched in June 2025. Eligible studies included cost-utility analysis and cost-effectiveness analysis of DBT compared with DM alone in women at average risk of breast cancer. Outcomes included costs and effectiveness, measured in quality-adjusted life years or life years gained. Study characteristics, modeling approaches, and cost-effectiveness results were extracted and narratively synthesized.</p><p><strong>Results: </strong>A total of 10 studies published between 2015 and 2025 were included, 5 assessing DBT with DM and 5 assessing standalone DBT. Conclusions varied from cost-saving to not cost-effective. Studies including women aged 40-74 years and modeling biennial screening generally found DBT to be cost-effective. Evidence for standalone DBT was limited but suggested potential cost savings in some settings.</p><p><strong>Conclusions: </strong>DBT may be a cost-effective intervention compared with DM for breast cancer screening. However, further robust economic evaluations, particularly of standalone DBT, are warranted to inform policy decision-making across diverse healthcare settings, particularly within Asian settings.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"20 4","pages":"208-229"},"PeriodicalIF":1.4,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13718366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of ginger for treating chemotherapy-induced nausea and vomiting in patients with cancer: a systematic review and meta-analysis. 生姜治疗癌症患者化疗引起的恶心和呕吐的疗效:系统回顾和荟萃分析。
IF 1.4 4区 医学
Asian Biomedicine Pub Date : 2026-08-31 eCollection Date: 2026-08-01 DOI: 10.2478/abm-2026-0030
Min Li, Qianjun Li, Xuecheng Zeng, Misbah Ullah Khan, Wei Cai
{"title":"The efficacy of ginger for treating chemotherapy-induced nausea and vomiting in patients with cancer: a systematic review and meta-analysis.","authors":"Min Li, Qianjun Li, Xuecheng Zeng, Misbah Ullah Khan, Wei Cai","doi":"10.2478/abm-2026-0030","DOIUrl":"https://doi.org/10.2478/abm-2026-0030","url":null,"abstract":"<p><strong>Background: </strong>Ginger has been shown to effectively decrease the risk of nausea and vomiting in different medical conditions. In this meta-analysis, we investigated the effect of ginger on the risk of nausea and vomiting after chemotherapy.</p><p><strong>Methods: </strong>We searched the Cochrane Library, Scopus, PubMed, and Web of Science from inception to April 17, 2025, to identify randomized controlled trials assessing the effect of ginger on the incidence of nausea and vomiting after chemotherapy.</p><p><strong>Results: </strong>Finally, we included 13 randomized controlled trials with 639 participants in the ginger group and 626 participants in the comparator group assessing the efficacy of ginger for chemotherapy-induced nausea and vomiting. Overall, the risk of bias was generally low, with only 2 studies showing high risks of bias. We found that ginger could not significantly lower the risk of acute nausea (RR 0.83, 95% CI (0.60, 1.15), <i>I</i> <sup>2</sup> = 38.35%) and acute vomiting (RR 0.73, 95% CI [0.51, 1.06], <i>I</i> <sup>2</sup> = 0.00%) after chemotherapy. Similarly, ginger did not significantly decrease the risk of delayed nausea (RR 0.92, 95% CI [0.66, 1.28], <i>I</i> <sup>2</sup> = 23.71%) and delayed vomiting (RR 1.17, 95% CI [0.75, 1.83], <i>I</i> <sup>2</sup> = 17.43%) among those receiving emetogenic chemotherapy. In subgroup analysis, age was the only factor associated with the preventive effect of ginger on chemotherapy-induced nausea and vomiting, and ginger was more effective among those younger than 50 years.</p><p><strong>Conclusion: </strong>This meta-analysis indicated that ginger could not significantly alter the risk of nausea and vomiting after chemotherapy.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"20 4","pages":"272-290"},"PeriodicalIF":1.4,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13718367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors, molecular features, and antibiotic susceptibility in carbapenem-resistant Enterobacterales infections among pediatric patients: a matched case-control study. 儿童患者碳青霉烯耐药肠杆菌感染的危险因素、分子特征和抗生素敏感性:一项匹配的病例对照研究。
IF 1.4 4区 医学
Asian Biomedicine Pub Date : 2026-08-31 eCollection Date: 2026-08-01 DOI: 10.2478/abm-2026-0029
Pintip Suchartlikitwong, Naris Kueakulpattana, Jiratchaya Sophonphan, Tanittha Chatsuwan
{"title":"Risk factors, molecular features, and antibiotic susceptibility in carbapenem-resistant Enterobacterales infections among pediatric patients: a matched case-control study.","authors":"Pintip Suchartlikitwong, Naris Kueakulpattana, Jiratchaya Sophonphan, Tanittha Chatsuwan","doi":"10.2478/abm-2026-0029","DOIUrl":"https://doi.org/10.2478/abm-2026-0029","url":null,"abstract":"<p><strong>Background: </strong>Carbapenem-resistant Enterobacterales (CRE) infections are a growing global concern, with limited data in children.</p><p><strong>Objectives: </strong>This study aimed to identify risk factors for pediatric CRE infections and characterize their resistance genes and antibiotic susceptibility.</p><p><strong>Methods: </strong>From January 2020 to March 2024, pediatric patients diagnosed with CRE infections >48 h after admission at a tertiary-care hospital in Bangkok were consecutively enrolled. A matched case-control study was conducted, pairing each CRE case 1:1 with a carbapenem-susceptible Enterobacterales (CSE) control based on infection site and age. Risk factors were analyzed using conditional logistic regression. Carbapenemase genes were detected using multiplex polymerase chain reaction, and antibiotic susceptibilities were determined by minimal inhibitory concentration testing.</p><p><strong>Results: </strong>Seventy-six CRE cases and 76 matched CSE controls were included. Urinary tract infections were most common (42.1%). Independent risk factors included referral from other hospitals (adjusted odds ratios [aOR] 4.32; 95% CI 1.57-11.96), prior exposure to carbapenems (aOR 7.24; 95% CI 1.06-25.42), and third-generation cephalosporins (aOR 3.68; 95% CI 1.32-10.25). <i>Klebsiella pneumoniae</i> (72.4%) predominated among CRE isolates; <i>Escherichia coli</i> (52.6%) among CSE. Carbapenemase genes were detected in 76.3% of CRE isolates, mainly <i>bla</i> <sub>NDM</sub> (60.3%) and <i>bla</i> <sub>OXA-48</sub> (51.7%). Among non-carbapenems, amikacin showed the highest susceptibility against CSE (98.7%), and colistin against CRE isolates (88.2%). Ceftazidime/avibactam susceptibility was 100% among non-carbapenemase-producing CRE and 63.3% among CRE isolates with <i>bla</i> <sub>OXA-48</sub>.</p><p><strong>Conclusions: </strong>Pediatric CRE infections are associated with healthcare exposures and prior broad-spectrum antibiotic use. The high prevalence of carbapenemase genes and reduced antibiotic susceptibility emphasize the need for enhanced surveillance and targeted therapies.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"20 4","pages":"260-271"},"PeriodicalIF":1.4,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13718362/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital health integration and technological advancements in Saudi Arabia's healthcare system: a comparative analysis of clustered and non-clustered hospitals. 沙特阿拉伯医疗保健系统的数字健康整合和技术进步:集群和非集群医院的比较分析。
IF 1.4 4区 医学
Asian Biomedicine Pub Date : 2026-08-31 eCollection Date: 2026-08-01 DOI: 10.2478/abm-2026-0026
Ahmed Abdullah Alshehri, Asaad Abdulrahman Abduljawad
{"title":"Digital health integration and technological advancements in Saudi Arabia's healthcare system: a comparative analysis of clustered and non-clustered hospitals.","authors":"Ahmed Abdullah Alshehri, Asaad Abdulrahman Abduljawad","doi":"10.2478/abm-2026-0026","DOIUrl":"https://doi.org/10.2478/abm-2026-0026","url":null,"abstract":"<p><strong>Background: </strong>Digital health is central to Saudi Arabia's Vision 2030, with hospital clustering introduced to improve efficiency, interoperability, and patient outcomes. However, comparative evidence on digital health adoption between clustered and non-clustered hospitals remains limited.</p><p><strong>Objectives: </strong>This study evaluates the integration of electronic medical records (EMRs), telemedicine, and mobile health applications in clustered and non-clustered hospitals in Saudi Arabia, assessing their impact on patient-centered care and system performance.</p><p><strong>Methods: </strong>A convergent mixed-methods observational design was applied. Quantitative hospital-level data (2016-2024) from two clustered and two non-clustered hospitals were analyzed for EMR adoption, telemedicine use, patient satisfaction, and chronic disease management. Logistic regression and ARIMA models assessed adoption patterns. Qualitative data were obtained through semi-structured interviews with 53 participants (30 patients, 23 physicians) purposively sampled from an initial pool of 80; saturation was reached at the 30th patient and 23rd physician. Thematic analysis identified facilitators, barriers, and perceived benefits.</p><p><strong>Results: </strong>Clustered hospitals consistently outperformed non-clustered hospitals across all digital health indicators. By 2024, clustered hospitals achieved higher Patient-Centered Care Index (95.1% vs. 92.2%) and Chronic Disease Management Scores (96.1% vs. 92.8%). Logistic regression showed clustered hospitals had 1.8-fold higher odds of EMR adoption (95% confidence interval [CI]: 1.3-2.5) and 2.1-fold higher odds of telemedicine use (95% CI: 1.5-2.8). Qualitative findings revealed facilitators (system integration, leadership support), barriers (digital illiteracy, fragmented systems, limited training), and perceived benefits (reduced waiting times, improved follow-up, patient engagement).</p><p><strong>Conclusions: </strong>Clustering enhances digital health adoption by strengthening interoperability, standardization, and institutional support. Persistent challenges, particularly in non-clustered hospitals, highlight the need for targeted investment in infrastructure, workforce training, and digital literacy to ensure equity in achieving Vision 2030 goals.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"20 4","pages":"230-239"},"PeriodicalIF":1.4,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13718359/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlations between serum acute-phase protein SAA, platelet-to-lymphocyte ratio, and disease activity in ankylosing spondylitis. 强直性脊柱炎患者血清急性期蛋白SAA、血小板与淋巴细胞比值和疾病活动性的相关性
IF 1.4 4区 医学
Asian Biomedicine Pub Date : 2026-08-31 eCollection Date: 2026-08-01 DOI: 10.2478/abm-2026-0027
NingNing Yu, TaiZhe Wang, ZhiGang Liu
{"title":"Correlations between serum acute-phase protein SAA, platelet-to-lymphocyte ratio, and disease activity in ankylosing spondylitis.","authors":"NingNing Yu, TaiZhe Wang, ZhiGang Liu","doi":"10.2478/abm-2026-0027","DOIUrl":"https://doi.org/10.2478/abm-2026-0027","url":null,"abstract":"<p><strong>Background: </strong>Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease characterized by sacroiliitis and spinal osteophyte formation that needs sophisticated testing to improve the accuracy of activity assessment and clinical decision-making.</p><p><strong>Objective: </strong>To investigate the clinical value of serum amyloid A (SAA) and platelet-to-lymphocyte ratio (PLR) in assessing disease activity in patients with AS.</p><p><strong>Methods: </strong>Using the bath ankylosing spondylitis disease activity index (BASDAI), 160 AS patients were categorized into 3 subgroups: low activity (BASDAI <4, n = 60), moderate activity (4≤ BASDAI <6, n = 50), and high activity (BASDAI ≥6, n = 50). Quantitative measurements included SAA concentrations and PLR values, with subsequent analysis of their relationship to disease progression. Diagnostic performance was evaluated with receiver operating characteristic (ROC) curve methodology.</p><p><strong>Results: </strong>The high-activity group showed significantly elevated SAA (48.3 mg/L ± 9.1 mg/L) and PLR (164.5 ± 29.2) versus moderate- (SAA: 29.0 mg/L ± 8.2 mg/L; PLR: 138.4 ± 27.6) and low-activity groups (SAA: 14.3 [11.7-17.2] mg/L; PLR: 102.7 ± 22.2) (all <i>P</i> < 0.001). Both markers correlated strongly with BASDAI (SAA: <i>r</i> = 0.76; PLR: <i>r</i> = 0.71, <i>P</i> < 0.001). ROC analysis demonstrated that an SAA cutoff of 30.6 mg/L predicted high activity (96% sensitivity, 80% specificity), while PLR ≥143.7 showed 78.0% sensitivity and 76.4% specificity. Combined detection achieved superior area under the curve (0.95) versus individual markers (SAA: 0.93; PLR: 0.86).</p><p><strong>Conclusion: </strong>SAA and PLR are strongly associated with BASDAI-defined disease activity in AS, and combined assessment improves identification of high disease activity, supporting their potential role as objective adjunctive markers in clinical assessment.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"20 4","pages":"240-247"},"PeriodicalIF":1.4,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13718364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monitoring disease activity of ankylosing spondylitis. 强直性脊柱炎疾病活动性监测。
IF 1.4 4区 医学
Asian Biomedicine Pub Date : 2026-08-31 eCollection Date: 2026-08-01 DOI: 10.2478/abm-2026-0024
{"title":"Monitoring disease activity of ankylosing spondylitis.","authors":"","doi":"10.2478/abm-2026-0024","DOIUrl":"https://doi.org/10.2478/abm-2026-0024","url":null,"abstract":"","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"20 4","pages":"206-207"},"PeriodicalIF":1.4,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13718363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dysregulated T helper cytokines in serum and peritoneal fluid of women with endometriosis-related infertility. 子宫内膜异位症相关性不孕症患者血清和腹膜液中辅助性T细胞因子失调
IF 1.4 4区 医学
Asian Biomedicine Pub Date : 2026-08-31 eCollection Date: 2026-08-01 DOI: 10.2478/abm-2026-0028
Fadhil Ahsan, Nanda Yuli Rahmawati, M Y Ardianta Widyanugraha, Arif Tunjungseto, Sri Ratna Dwiningsih, Ashon Sa'adi, Budi Santoso
{"title":"Dysregulated T helper cytokines in serum and peritoneal fluid of women with endometriosis-related infertility.","authors":"Fadhil Ahsan, Nanda Yuli Rahmawati, M Y Ardianta Widyanugraha, Arif Tunjungseto, Sri Ratna Dwiningsih, Ashon Sa'adi, Budi Santoso","doi":"10.2478/abm-2026-0028","DOIUrl":"https://doi.org/10.2478/abm-2026-0028","url":null,"abstract":"<p><strong>Background: </strong>Endometriosis is a chronic inflammatory condition and is one of the leading causes of infertility. The role of T helper (Th) cytokines in infertility remains largely unexamined, despite their recognized importance in endometriosis.</p><p><strong>Objectives: </strong>To investigate the serum and peritoneal fluid levels of IL-4, IL-5, IL-10, IL-17A, IL-17F, and IFN-γ in women with endometriosis and to explore their correlations with disease severity.</p><p><strong>Methods: </strong>Eighty-seven infertile women undergoing diagnostic laparoscopy were included, comprising 44 endometriosis patients and 43 controls with benign gynecologic disorders. Serum and peritoneal cytokines were measured using Enzyme-linked immunosorbent assay. Statistical analyses assessed differences and correlations with clinical parameters.</p><p><strong>Results: </strong>Both serum and peritoneal fluid levels of IL-4 and IL-5 were markedly higher in endometriosis patients compared to controls (<i>P</i> < 0.001). Although serum IL-10 levels did not show significant differences, there was an increase in peritoneal fluid (<i>P</i> < 0.001). Among those with endometriosis, serum levels of IL-4, IL-10, IL-17A, and IL-17F exhibited a positive correlation with the revised American Society for Reproductive Medicine score, while IL-17F indicated an inverse correlation with the Endometriosis Fertility Index (EFI) scores (<i>r</i> = -0.422, <i>P</i> = 0.004). Receiver operating characteristic curve analysis demonstrated that IL-4 and IL-5 effectively distinguished endometriosis cases from controls, with IL-17F also providing significant predictive value for EFI scores (<i>P</i> = 0.015).</p><p><strong>Conclusions: </strong>Elevated IL-4 and IL-5 levels in endometriosis suggest a Th2-skewed immune response. Meanwhile, the correlation of IL-17A with disease severity and the inverse relationship of IL-17F with fertility scores highlight the complex role of the Th17 response. These findings enhance understanding of cytokine dysregulation in endometriosis and may guide future therapeutic strategies.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"20 4","pages":"248-259"},"PeriodicalIF":1.4,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13718365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive analysis of the incidence of chromosomal abnormalities in hematologic malignancies post-COVID-19 outbreak in King Chulalongkorn Memorial Hospital, Thailand. 泰国朱拉隆功国王纪念医院新冠肺炎疫情后血液系统恶性肿瘤染色体异常发生率综合分析
IF 1.4 4区 医学
Asian Biomedicine Pub Date : 2026-06-30 eCollection Date: 2026-06-01 DOI: 10.2478/abm-2026-0022
Montakarn Tansatit, Nutcharee Jongpornchai, Suwannee Songchart, Kittipornpan Krajokpap, Hudadini Da-Oh
{"title":"A comprehensive analysis of the incidence of chromosomal abnormalities in hematologic malignancies post-COVID-19 outbreak in King Chulalongkorn Memorial Hospital, Thailand.","authors":"Montakarn Tansatit, Nutcharee Jongpornchai, Suwannee Songchart, Kittipornpan Krajokpap, Hudadini Da-Oh","doi":"10.2478/abm-2026-0022","DOIUrl":"10.2478/abm-2026-0022","url":null,"abstract":"<p><strong>Background: </strong>Hematologic malignancies, including leukemia, lymphoma, and bone marrow disorders, are complex cancers often associated with chromosomal abnormalities. The emergence of COVID-19 raised concerns about its potential to induce genomic instability, influencing the prevalence and cytogenetics of these malignancies.</p><p><strong>Objectives: </strong>This study evaluates whether the COVID-19 pandemic affected the incidence, demographics, or chromosomal abnormalities in hematologic malignancies at King Chulalongkorn Memorial Hospital, Thailand, between 2018 and 2024.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 3,077 bone marrow samples processed for cytogenetic evaluation. Samples were categorized into pre-COVID-19 (2018-2019) and post-COVID-19 (2020-2024) periods. Trends in disease incidence, patient demographics, and chromosomal abnormalities were analyzed statistically.</p><p><strong>Results: </strong>The overall incidence rates of hematologic malignancies, including leukemia, lymphoma, and bone marrow disorders, remained stable throughout the study. Male-to-female ratios and average ages of onset showed no significant changes. Except for a transient rise in chromosomal abnormalities in chronic lymphocytic leukemia during 2023, no new or recurring abnormalities were identified. The mean age of onset for various malignancy categories remained consistent across the study period, and the pandemic did not significantly alter hematologic cancer trends.</p><p><strong>Conclusions: </strong>The findings indicate that the COVID-19 pandemic did not substantially affect the incidence, cytogenetics, or demographics of hematologic malignancies. These results provide reassurance about the resilience of diagnostic and monitoring systems during the pandemic. Further studies are recommended to explore potential long-term implications of COVID-19 on hematologic malignancies.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"20 3","pages":"194-201"},"PeriodicalIF":1.4,"publicationDate":"2026-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13427362/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148652915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of lactoferrin and progesterone on the endometriotic lesion in a female rat model. 乳铁蛋白和孕酮对雌性大鼠子宫内膜异位症病变的影响。
IF 1.4 4区 医学
Asian Biomedicine Pub Date : 2026-06-30 eCollection Date: 2026-06-01 DOI: 10.2478/abm-2026-0019
İrem Şenyuva, Duygu Baki Acar, Hasan Hüseyin Demirel Bayat, Funda Karabağ, Ece Tunç
{"title":"Effects of lactoferrin and progesterone on the endometriotic lesion in a female rat model.","authors":"İrem Şenyuva, Duygu Baki Acar, Hasan Hüseyin Demirel Bayat, Funda Karabağ, Ece Tunç","doi":"10.2478/abm-2026-0019","DOIUrl":"10.2478/abm-2026-0019","url":null,"abstract":"<p><strong>Background: </strong>Lactoferrin (LF), a multifunctional glycoprotein of the transferrin family, exhibits anti-inflammatory and immunomodulatory properties. Endometriosis is an estrogen-dependent chronic inflammatory disease commonly treated with progesterone therapy; however, progesterone receptor (PGR) resistance in endometriotic lesions has increased interest in immunomodulatory approaches.</p><p><strong>Objective: </strong>To evaluate the effects of LF alone and combined with progesterone on endometriotic lesions in a rat model.</p><p><strong>Methods: </strong>An endometriosis model was induced in female Wistar Albino rats. Rats with confirmed endometriotic lesions were randomly divided into 4 equal groups and received the following oral treatments: Control (0.5% carboxymethylcellulose), bovine LF (bLF) (100 mg/kg/d), progesterone (0.3 mg/kg/day), combination therapy (bLF [100 mg/kg/d] + progesterone [0.3 mg/kg/d]). After treatment, the rats were euthanized, histopathological and biochemically anayses were done.</p><p><strong>Results: </strong>No statistically significant differences were observed in volume and adhesion scores of endometriotic lesions before and after treatment (<i>P</i> = 0.653, <i>P</i> = 0.413, <i>P</i> = 0.890, respectively). However, PGR and inflammatory cytocine levels were decreased in all treatment groups (<i>P</i> = 0.001). Although serum progesterone levels did not differ between groups (<i>P</i> = 0.06), serum LF levels were lower in the progesterone-only group (<i>P</i> = 0.001). Total antioxidant status (TAS) and Plasma total oxidant status (TOS) showed no significant differences among groups (<i>P</i> = 0.623 and <i>P</i> = 0.318, respectively).</p><p><strong>Conclusion: </strong>LF, alone or combined with progesterone, reduced inflammatory cytokine levels associated with endometriosis-related pain, suggesting potential therapeutic value. Further studies are needed to clarify its role in progesterone resistance and the clinical management of endometriosis.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"20 3","pages":"161-169"},"PeriodicalIF":1.4,"publicationDate":"2026-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13427365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148652891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-tuberculosis drug-induced hepatotoxicity in people living with HIV. 抗结核药物对艾滋病毒感染者的肝毒性。
IF 1.4 4区 医学
Asian Biomedicine Pub Date : 2026-06-30 eCollection Date: 2026-06-01 DOI: 10.2478/abm-2026-0016
{"title":"Anti-tuberculosis drug-induced hepatotoxicity in people living with HIV.","authors":"","doi":"10.2478/abm-2026-0016","DOIUrl":"10.2478/abm-2026-0016","url":null,"abstract":"","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":"20 3","pages":"147-148"},"PeriodicalIF":1.4,"publicationDate":"2026-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13427360/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148652840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书